ED

Mar 14 2026BUSINESS

Palantir Joins the Sports‑Betting Race – Is It Worth Buying?

Palantir, a data‑analysis giant, has just signed a deal with Polymarket to build a new sports‑betting platform. The partnership will use Palantir’s AI engine to spot shady trades and block banned bettors in real time. This move ties Palantir to a market that is under heavy legal scrutiny. The U. S.

reading time less than a minute
Mar 14 2026TECHNOLOGY

Japan Grants Green Light to First Cell‑Reprogrammed Treatment

A new medical breakthrough has reached a milestone in Japan: the government has approved the first therapy that uses human cells reprogrammed back to a stem‑cell state. This approval marks the start of a new era where damaged tissues can be replaced by cells that grow into the needed type. The appro

reading time less than a minute
Mar 13 2026POLITICS

CNN’s New Owner Could Change the Game

The Pentagon chief said he hopes a billionaire named David Ellison will own CNN soon, thinking it might make the news better. Ellison owns a big movie company and is close to former President Trump. He wants to buy the network through his other business that already plans to take over a larger me

reading time less than a minute
Mar 13 2026HEALTH

Epicardial Pulse‑Field Breaks Bachmann’s Bundle Heartbeats

A new technique uses short bursts of electric energy to stop abnormal heart rhythms that start in a specific area called Bachmann’s bundle. Doctors first locate the problem spot from outside the heart, then deliver a pulsed‑field shock that destroys only the faulty cells. This method works without d

reading time less than a minute
Mar 13 2026HEALTH

Drip Deals: Are IV Vitamins a Smart Choice?

People are lining up at colorful “drip bars” across the state, paying $200 to $600 for vitamin infusions that promise quick recovery from a hangover, clearer skin, or better focus. A 34‑year‑old lawyer who usually caught two colds a year says the experience helped him stop getting sick altogether. T

reading time less than a minute
Mar 13 2026SPORTS

Kentucky vs Florida: A Third‑Time Showdown

Kentucky’s basketball team is back in the spotlight as it faces Florida once more, this time for a spot in the SEC Tournament semifinals. The Gators have already beaten the Wildcats twice this season, so many fans wonder if fatigue or past experience will tilt the balance. Kentucky has had a hard ro

reading time less than a minute
Mar 13 2026SPORTS

Ravens’ Medical Check Turns Trade on Its Head

The Baltimore Ravens pulled back a deal that had moved defensive lineman Maxx Crosby from the Las Vegas Raiders, citing concerns raised during a medical evaluation. The trade had been announced earlier in the week, with Baltimore offering first‑round draft picks for 2026 and 2027. But a second look

reading time less than a minute
Mar 13 2026CRIME

Old Man Trips Back to the Store, Young Drivers Speed Down Roads

In late February, a 73‑year‑old man from Aurora found himself back outside a local convenience store. He had been legally barred from the premises on December 6, and after slipping into it again on December 10, he received a trespassing ticket. He didn’t show up for the court date that followed. Whe

reading time less than a minute
Mar 13 2026BUSINESS

Live Nation’s Slack Scandal Hits Court

A new set of internal chat messages from Live Nation has surfaced in a federal trial. The chats, sent on Slack between late 2021 and early 2023, show a staff member calling fans “so stupid” and bragging that the company is “robbing them blind. ” These messages are now part of a lawsuit filed by t

reading time less than a minute
Mar 13 2026ENTERTAINMENT

Nick Barrotta Joins Untitled Entertainment After Success on The Oval

Barrotta, who first gained fame playing Allan in Tyler Perry’s BET series The Oval, has just signed with Untitled Entertainment. The actor’s career began in New York where he balanced journalism gigs at Entertainment Tonight, Celebuzz and The Wrap before moving into acting. He appeared in over

reading time less than a minute